Phreesia’s (PHR) “Buy” Rating Reiterated at Needham & Company LLC

Needham & Company LLC reaffirmed their buy rating on shares of Phreesia (NYSE:PHR) in a research note released on Monday,Benzinga reports. Needham & Company LLC currently has a $14.00 price objective on the stock.

PHR has been the topic of several other reports. Canaccord Genuity Group decreased their target price on shares of Phreesia from $22.00 to $16.00 and set a “buy” rating on the stock in a research note on Thursday, May 28th. Piper Sandler cut shares of Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 price target for the company. in a research report on Thursday, May 28th. Barclays reissued an “equal weight” rating and issued a $10.00 price target (down from $24.00) on shares of Phreesia in a report on Thursday, May 14th. Truist Financial boosted their price objective on shares of Phreesia from $11.00 to $12.00 and gave the company a “hold” rating in a research report on Thursday, May 28th. Finally, Citigroup reaffirmed a “market perform” rating on shares of Phreesia in a research note on Friday, May 29th. Nine investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Phreesia currently has an average rating of “Hold” and an average target price of $16.65.

Phreesia Price Performance

Shares of Phreesia stock opened at $11.88 on Monday. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76. The business’s 50 day simple moving average is $11.19 and its two-hundred day simple moving average is $10.48. The stock has a market capitalization of $734.30 million, a P/E ratio of 79.20 and a beta of 0.86. Phreesia has a one year low of $7.77 and a one year high of $31.83.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Wednesday, September 2nd. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.06). The company had revenue of $129.46 million during the quarter, compared to the consensus estimate of $129.06 million. Phreesia had a net margin of 1.85% and a return on equity of 5.13%. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.01 EPS. Analysts forecast that Phreesia will post 0.39 EPS for the current year.

Institutional Trading of Phreesia

Large investors have recently added to or reduced their stakes in the stock. Van ECK Associates Corp lifted its position in shares of Phreesia by 78.7% in the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after purchasing an additional 1,102 shares during the period. Rockefeller Capital Management L.P. boosted its stake in shares of Phreesia by 354.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after purchasing an additional 2,149 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Phreesia by 1,119.8% during the first quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock valued at $27,000 after buying an additional 3,001 shares during the period. Garner Asset Management Corp purchased a new position in shares of Phreesia during the fourth quarter valued at about $81,000. Finally, New York State Teachers Retirement System purchased a new position in shares of Phreesia during the first quarter valued at about $44,000. Institutional investors own 92.10% of the company’s stock.

Key Stories Impacting Phreesia

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Phreesia generated positive operating and free cash flow for the quarter and reduced debt principal by more than $23 million, strengthening its balance sheet and supporting profitability expansion. Phreesia Announces Second Quarter Fiscal 2027 Results
• Positive Sentiment: Management maintained fiscal 2027 revenue guidance of $510 million to $520 million, broadly in line with the $515 million analyst consensus, reducing the risk of a near-term outlook cut. The company also identified AccessOne as a potential multi-year growth driver. Phreesia maintains FY2027 revenue outlook
• Positive Sentiment: Needham & Company issued a Buy rating, providing favorable analyst support for PHR following the earnings release. Phreesia Earns Buy Rating from Needham
• Neutral Sentiment: Revenue reached $129.46 million, up 10.4% year over year and slightly above the $129.06 million consensus estimate, indicating continued growth but not a major top-line upside surprise. Phreesia fiscal second-quarter results
• Negative Sentiment: Quarterly EPS was $0.03, below analyst expectations of approximately $0.09 to $0.11, although it improved from $0.01 in the prior-year quarter. The earnings shortfall may weigh on investor sentiment despite the company’s cash-flow progress. Phreesia Q2 earnings and revenues lag estimates

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.